Showing results (151-160 of 221) with videos related to
Sort By:
Pageof 23
American Journal of Clinical Oncology|February 6, 2009
A phase I dose-escalation study of SR271425, an intravenously dosed thioxanthone analog, administered weekly in patients with refractory solid tumorsA Craig Lockhart, Emiliano Calvo, Anthony W Tolcher, et al.American Journal of Clinical Oncology|January 11, 2011
Dual blockade of the EGFR and COX-2 pathways: a phase II trial of cetuximab and celecoxib in patients with chemotherapy refractory metastatic colorectal cancerEmily Chan, Bonnie Lafleur, Mace L Rothenberg, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 2006
Pooled analysis of safety and efficacy of oxaliplatin plus fluorouracil/leucovorin administered bimonthly in elderly patients with colorectal cancerRichard M Goldberg, Isabelle Tabah-Fisch, Harry Bleiberg, et al.Cancer|November 7, 1998
Dose intensive combination platinum and cyclophosphamide in the treatment of patients with advanced untreated epithelial ovarian cancerJ D Shapiro, M L Rothenberg, G A Sarosy, et al.Urology|June 1, 1986
Impact of magnetic resonance on staging of renal carcinomaP Ramchandani, R L Soulen, R I Schnall, et al.Annals of the New York Academy of Sciences|January 31, 2004
Clinical studies in patients with solid tumors using a second-generation antisense oligonucleotide (GEM 231) targeted against protein kinase A type IS Mani, S Goel, M Nesterova, et al.Urologic Radiology|January 1, 1988
Postnephrectomy pseudoaneurysm with arteriovenous fistulaS D Herman, P D Radecki, A C Friedman, et al.Investigational New Drugs|May 9, 2008
Phase I trial of pemetrexed plus oxaliplatin administered every other week in patients with metastatic cancerDaniel G Stover, A Craig Lockhart, Jordan D Berlin, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 14, 2008
Capecitabine plus oxaliplatin (XELOX) versus 5-fluorouracil/folinic acid plus oxaliplatin (FOLFOX-4) as second-line therapy in metastatic colorectal cancer: a randomized phase III noninferiority studyM L Rothenberg, J V Cox, C Butts, et al.The American Journal on Addictions|April 6, 2006
Predictors of retention in naltrexone maintenance for opioid dependence: analysis of a stage I trialMaria A Sullivan, Jami L Rothenberg, Suzanne K Vosburg, et al.Pageof 23